0000059478-21-000239.txt : 20211117 0000059478-21-000239.hdr.sgml : 20211117 20211117172344 ACCESSION NUMBER: 0000059478-21-000239 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20211115 FILED AS OF DATE: 20211117 DATE AS OF CHANGE: 20211117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ESKEW MICHAEL L CENTRAL INDEX KEY: 0001227734 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 211421586 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ELI LILLY & Co CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 FORMER COMPANY: FORMER CONFORMED NAME: LILLY ELI & CO DATE OF NAME CHANGE: 19941024 4 1 wf-form4_163718780965014.xml FORM 4 X0306 4 2021-11-15 0 0000059478 ELI LILLY & Co LLY 0001227734 ESKEW MICHAEL L LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 1 0 0 0 Common Stock 2021-11-15 4 A 0 677 258.43 A 45080 D Exhibit 24 Power of Attorney Jonathan Groff for Michael L. Eskew, authorization attached 2021-11-17 EX-24 2 eskewpoa.htm ESKEW_POA
Michael L. Eskew
Lilly Corporate Center
Indianapolis, Indiana 46285



Securities and Exchange Commission
Washington, D.C. 20549

Authorization Regarding Reporting Forms

I hereby authorize and designate the following persons to sign and file with the Commission on my behalf Forms 3, 4, and 5 (including any amendments thereto) covering my transactions and holdings in the common stock and other equity securities of Eli Lilly and Company as required by Section 16 of the Securities Exchange Act of 1934 and the rules thereunder:

    Anat Hakim, Lilly Corporate Center, Indianapolis, Indiana

    Erin Conway, Lilly Corporate Center, Indianapolis, Indiana

    Jonathan Groff, Lilly Corporate Center, Indianapolis, Indiana

This authorization and designation shall remain in effect until a written revocation is signed by me and provided to the Commission.

Date: August 11, 2021

/s/ Michael L. Eskew